头对头分析：Cutera 与 Semler Scientific。 Head-To-Head Analysis: Cutera vs. Semler Scientific.

在对小型医疗公司 Semler Scientific 和 Cutera 的正面比较中，分析师青睐 Cutera，一致的价格目标表明潜在上涨空间为 903.40%。 In a head-to-head comparison of small-cap medical companies Semler Scientific and Cutera, analysts favor Cutera, with a consensus price target indicating a potential upside of 903.40%. Cutera 价格更实惠，市盈率更低，机构持股比例更高，产品组合更广泛。 Cutera is more affordable with a lower price-to-earnings ratio, higher institutional ownership, and a broader product portfolio. 与标准普尔 500 指数相比，Semler Scientific 的收益较高，但收入较低，且股价波动性较低。 Semler Scientific has higher earnings but lower revenue, and a lower stock price volatility than the S&P 500.